Catalyst Funds Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362K Sell
1,000
-1,453
-59% -$497K 0.02% 465
2026
Q1
$863K Buy
2,453
+473
+24% +$169K 0.15% 171
2025
Q4
$648K Buy
1,980
+1,080
+120% +$343K 0.15% 148
2025
Q3
$254K Buy
+900
New +$261K 0.04% 363
2025
Q2
Sell
-1,800
Closed -$561K 443
2025
Q1
$561K Buy
+1,800
New +$532K 0.15% 171
2024
Q4
Sell
-1,200
Closed -$387K 347
2024
Q3
$387K Sell
1,200
-1,400
-54% -$458K 0.08% 162
2024
Q2
$812K Buy
2,600
+800
+44% +$235K 0.22% 73
2024
Q1
$512K Buy
+1,800
New +$527K 0.14% 129

Other funds holding AMGN

Catalyst Funds Management's AMGN Position: Q2 2026 in Review

Catalyst Funds Management reduced its Amgen (AMGN) stake by 59% in Q2 2026, selling an estimated $497K and leaving 1,000 shares worth $362K. The position accounts for 0.02% of the portfolio, ranked #465.

Catalyst Funds Management first reported a position in AMGN in Q1 2024 and has held it in 8 quarters since. The position peaked at $863K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Catalyst Funds Management held 1,000 shares of Amgen worth $362K as of Q2 2026.
  • Catalyst Funds Management sold 1,453 Amgen shares in Q2 2026, an estimated $497K.
  • Amgen made up 0.02% of Catalyst Funds Management's portfolio in Q2 2026, its #465 holding.
  • Catalyst Funds Management first reported a position in Amgen in Q1 2024 and has held it in 8 quarters since.
  • Catalyst Funds Management's Amgen position peaked at $863K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.